Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
769.50    4.50 (0.59%)
Bid:
770.00
Ask:
772.50
Spread: 2.50 (0.325%)
Market Cap: £886.26m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

4 Sep 2019 07:00

RNS Number : 7021K
Kainos Group plc
04 September 2019
Β 

4 September 2019

Kainos Group plc

("Kainos" or "the Company")

Trading Update

Β 

Kainos, a leading UK-based provider of digital services and platforms, today issues a trading update for the period from 1 April 2019 to date. The Company expects results for the full year ending 31 March 2020 to be in line with current market expectations.

Β 

The Group has delivered a solid Digital Services performance with positive momentum across government, healthcare and commercial clients. Digital Transformation has made progress within the Commercial sector whilst continuing to be a key supplier in the UK Government's digital transformation programme. In relation to the latter, the Group remains cautious about public sector spending in the current political environment.

Β 

In Workday Services, the Group continues to benefit from an increasing book of business in continental Europe and North America following geographic expansion. Digital Platforms growth has been driven by Smart, our Workday automated testing platform, where we have continued to win new clients and drive very strong growth.

Β 

The announcement of Kainos' results for the six months ended 30 September 2019 will be made on Monday 11 November 2019.

Β 

For further information, please contact:

Β 

Kainos

via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Β 

Investec Bank plc

Patrick Robb / Sebastian Lawrence

+44Β 20 7597 5970

Canaccord Genuity

+44 20 7523 4606

Simon Bridges

Β 

FTI Consulting LLP

+44 20 3727 1000

Matt Dixon / Harry Staight

Β 

Β 

About Kainos

KainosΒ Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.Β 

Β 

The Group's Digital Services include full lifecycle development and support ofΒ customisedΒ Digital Services for government and commercial customers.Β KainosΒ is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.Β 

Β 

The Group's Digital Platforms compriseΒ specialisedΒ digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for theΒ digitisationΒ of patient notes in the Acute sector of the NHS.

Β 

Kainos has over 1,470Β people across 12 offices in Europe and North America.Β Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTPMMPTMBJJMLL
Date   Source Headline
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 202511:01 amRNSNotice of Annual General Meeting 2025
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202510:44 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20254:47 pmRNSAnnual Report 2025
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSAppointment of Independent Non-Executive Director
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20252:24 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 202511:24 amRNSDirector / PDMR shareholdings
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20254:55 pmRNSNotification of Major Holdings
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.